- Home
- BNBX vs ENVB Comparison
BNBX vs ENVB Comparison
Compare BNBX & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | ENVB |
|---|---|---|
| Founded | 1983 | 1994 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.0M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | BNBX | ENVB |
|---|---|---|
| Price | $0.47 | $2.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 303.8K | ★ 7.9M |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,914,675.00 |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $0.56 |
| 52 Week High | $6.17 | $13.25 |
Technical Indicators
Market Signals| Indicator | BNBX | ENVB |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 37.91 |
| Support Level | $0.45 | $1.82 |
| Resistance Level | $0.85 | $4.48 |
| Average True Range (ATR) | 0.03 | 0.50 |
| MACD | 0.00 | -0.25 |
| Stochastic Oscillator | 17.37 | 2.07 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.